Clinical trials
Withdrawn Phase 2 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardeas Pharma | 1 |
| Eli Lilly and Company | 1 |
| Pfizer | 1 |
| Samsung Medical Center | 1 |
| University of New Mexico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 5 |
| Respiratory Tract Diseases | 3 |
| Pneumonia | 2 |
| Respiratory Tract Infections | 2 |
| Bacterial Infections | 1 |
| COVID-19 | 1 |
| Coronaviridae Infections | 1 |
| Coronavirus Infections | 1 |
| Infections | 1 |
| Lung Neoplasms | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.